<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Med</journal-id><journal-id journal-id-type="iso-abbrev">J. Exp. Med</journal-id><journal-title-group><journal-title>The Journal of Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">0022-1007</issn><issn pub-type="epub">1540-9538</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">9874578</article-id><article-id pub-id-type="pmc">PMC1887698</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Definitive Reports</subject></subj-group></article-categories><title-group><article-title>Leptin Is an Endogenous Protective Protein against the Toxicity Exerted by Tumor Necrosis Factor </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Takahashi</surname><given-names>Nozomi</given-names></name><xref ref-type="aff" rid="N0x1bf23c0N0x1ffe4a8">*</xref></contrib><contrib contrib-type="author"><name><surname>Waelput</surname><given-names>Wim</given-names></name><xref ref-type="aff" rid="N0x1bf23c0N0x1ffe4a8">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Guisez</surname><given-names>Yves</given-names></name><xref ref-type="aff" rid="N0x1bf23c0N0x1ffe4a8">&#x000a7;</xref></contrib></contrib-group><aff id="N0x1bf23c0N0x1ffe4a8">From the <label>*</label>Molecular Pathophysiology and Experimental Therapy Unit, Department of Molecular Biology; and the <label>&#x02021;</label>Department of Medical Protein Research, Flanders Interuniversity Institute for Biotechnology and University of Ghent, B-9000 Ghent, Belgium; and <label>&#x000a7;</label>Roche Research Ghent, B-9000 Ghent, Belgium</aff><author-notes><fn><p>Address correspondence to N. Takahashi, Department of Molecular Biology, K.L. Ledeganckstraat 35, B-9000 Ghent, Belgium. Phone: 32-9-264-51-31; Fax: 32-9-264-53-48; E-mail: <email>nozomi.takahashi@dmb.rug.ac.be</email>
</p></fn></author-notes><pub-date pub-type="ppub"><day>4</day><month>1</month><year>1999</year></pub-date><volume>189</volume><issue>1</issue><fpage seq="a">207</fpage><lpage>212</lpage><history><date date-type="received"><day>17</day><month>6</month><year>1998</year></date><date date-type="rev-recd"><day>15</day><month>10</month><year>1998</year></date></history><permissions><copyright-year>1999</copyright-year><license license-type="openaccess"><license-p>This article is distributed under the terms of an Attribution&#x02013;Noncommercial&#x02013;Share Alike&#x02013;No Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.rupress.org/terms">http://www.rupress.org/terms</ext-link>). After six months it is available under a Creative Commons License (Attribution&#x02013;Noncommercial&#x02013;Share Alike 4.0 Unported license, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Tumor necrosis factor (TNF) is a central mediator of a number of important pathologies such as the systemic inflammatory response syndrome. Administration of high TNF doses induces acute anorexia, metabolic derangement, inflammation, and eventually shock and death. The in vivo effects of TNF are largely mediated by a complex network of TNF-induced cytokines and hormones acting together or antagonistically. Since TNF also induces leptin, a hormone secreted by adipocytes that modulates food intake and metabolism, we questioned the role of leptin in TNF-induced pathology. To address this question, we tested mouse strains that were defective either in leptin gene (<italic>ob/ob</italic>) or in functional leptin receptor gene (<italic>db/db</italic>), and made use of a receptor antagonist of leptin. <italic>Ob/ob</italic> and <italic>db/db</italic> mice, as well as normal mice treated with antagonist, exhibited increased sensitivity to the lethal effect of TNF. Exogenous leptin afforded protection to TNF in <italic>ob/ob</italic> mice, but failed to enhance the protective effect of endogenous leptin in normal mice. We conclude that leptin is involved in the protective mechanisms that allow an organism to cope with the potentially autoaggressive effects of its immune system.</p></abstract><kwd-group><kwd>leptin</kwd><kwd>tumor necrosis factor</kwd><kwd>anorexia</kwd><kwd>shock</kwd><kwd>obesity</kwd></kwd-group></article-meta></front><body><p>Tumor necrosis factor (TNF) is a pleiotropic cytokine with potent antitumor activity; however, it is also involved in the pathogenesis of many inflammatory diseases. Above all, TNF is a central mediator of the potentially lethal systemic inflammatory response syndrome (<xref rid="B1" ref-type="bibr">1</xref>). A single injection of TNF into animals causes acute anorexia, weight loss, metabolic derangement, hypotension, and, at very high doses, shock and death as a result of a widespread systemic inflammatory reaction (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). However, prolonged treatment with lower doses of TNF results in tachyphylaxis and tolerance (<xref rid="B4" ref-type="bibr">4</xref>&#x02013;<xref rid="B6" ref-type="bibr">6</xref>). These effects are largely mediated by a complex network of cytokines, hormones, and low-molecular weight mediators induced by TNF (<xref rid="B7" ref-type="bibr">7</xref>). This network is not only responsible for the deleterious outcome, but also for the induction of often more complex endogenous protection mechanisms whose function allows the organism to cope with the potentially autoaggressive consequences of immune/inflammatory reactions. Glucocorticoid hormones represent the most powerful antiinflammatory arm (<xref rid="B8" ref-type="bibr">8</xref>), whereas some proinflammatory cytokines, such as IL-1 and IL-6, play a dual role by also contributing to protective mechanisms via induction of acute-phase proteins (<xref rid="B9" ref-type="bibr">9</xref>). Some acute-phase proteins act as protease inhibitors to limit the destructive effects of TNF-induced proteases (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). The exact significance of each of these mediators is far from established. In this study we wanted to investigate the role of leptin, which was described as being induced by TNF (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>). Leptin is the product of the <italic>ob</italic> gene associated with obesity (<xref rid="B14" ref-type="bibr">14</xref>). Mutant mice with a defective leptin gene (<italic>ob/ob</italic>) or leptin receptor gene (<italic>db/db</italic>) exhibit hyperphagia, reduced energy expenditure, and obesity (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>). Administration of leptin was found to reduce food intake in both normal and <italic>ob/ob</italic> mice (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). Recently, a specific receptor antagonist of leptin was obtained by introducing a point mutation into the human leptin gene (<xref rid="B19" ref-type="bibr">19</xref>). This leptin mutein binds to the leptin receptor but fails to transduce a signal. When injected into normal mice, the leptin antagonist induced weight gain (<xref rid="B19" ref-type="bibr">19</xref>). Given the possible link between TNF and leptin on the production level, we speculated on the role of leptin in TNF-induced effects. Using mutant mouse strains and antagonist, we investigated the role of endogenous leptin in TNF-induced lethality.</p><sec sec-type="materials|methods" id="MaterialsMethods"><title>Materials and Methods</title><sec disp-level="3"><title>Animals.</title><p> Specific pathogen&#x02013;free female C57BL/6 mice, 8&#x02013;12 wk old at the beginning of the experiments, were obtained from Charles River Labs. Specific pathogen&#x02013;free C57BL/6J mice (referred to as wild-type [wt]), C57BL/6-ob mice (referred to as <italic>ob/ob</italic>), and C57BL/Ks-db mice (further referred to as <italic>db/db</italic>) were obtained from Harlan/Olac and The <named-content content-type="company" xlink:href="jackson">Jackson Laboratory</named-content>. The animals were housed in a temperature-controlled environment with 12-h light/dark cycles and received food and water ad libitum. All experiments were performed according to the European Union Guidelines on Animal Care and Use.</p></sec><sec disp-level="3"><title>Reagents.</title><p> Recombinant murine TNF (mTNF), produced by <italic>Escherichia coli</italic> containing an appropriate expression plasmid (<xref rid="B20" ref-type="bibr">20</xref>), was purified to apparent homogeneity. The specific activity was 2 &#x000d7; 10<sup>8</sup> IU/mg as determined in a cytotoxicity assay on L929 cells (<xref rid="B21" ref-type="bibr">21</xref>). Reference mTNF (code 88/532) was from the National Institute for Biological Standards and Control (Potters Bar, UK). The endotoxin content was &#x0003c;0.2 ng/mg, as assessed by a chromogenic <italic>Limulus amebocyte</italic> lysate assay (Coatest; Chromogenix, Stockholm, Sweden). Human wt leptin was produced by baculovirus-infected insect cells (<xref rid="B22" ref-type="bibr">22</xref>) and purified on an immunoaffinity column as described previously (<xref rid="B19" ref-type="bibr">19</xref>); the endotoxin content amounted to 2.5 ng/mg. R128Q, an antagonist of human leptin, was created by site-directed mutagenesis and selected for its inhibitory activity on leptin sensitive-BAF3 1423 cells (<xref rid="B19" ref-type="bibr">19</xref>); the endotoxin content amounted to 2.1 ng/mg. 2A5, a monoclonal antibody directed against human leptin, was purified from hybridoma supernatant (<xref rid="B19" ref-type="bibr">19</xref>); the endotoxin content was 0.09 ng/ mg protein. All reagents were diluted in endotoxin-free PBS before injection.</p></sec><sec disp-level="3"><title>Treatment.</title><p> In experiments involving comparison of the sensitivity of different mouse strains, mice were challenged with sublethal doses of mTNF given intravenously. mTNF is lethal in normal mice at a dose of &#x0223c;20 &#x003bc;g (<xref rid="B23" ref-type="bibr">23</xref>). Survival was monitored for up to 60 h. There were no further deaths during the 1-wk period of follow-up. In experiments assessing the effect of leptin or leptin antagonist in TNF toxicity, mice were pretreated intraperitoneally with either agent in combination with an antibody (twice daily for 2 d and immediately before the challenge with varying doses of mTNF intravenously). Doses of leptin and leptin antagonist R128Q were 100 &#x003bc;g/mouse; doses of antibody 2A5 were 1 mg/mouse or 100 &#x003bc;g/mouse. Leptin and R128Q are cleared from the circulation very rapidly. The antibody 2A5 raised against human leptin also binds to R128Q and dramatically prolongs the biological half-life of both wt and mutant leptin mice. It was also demonstrated that the biological effects of leptin and the antagonist in wt mice are only seen in the presence of antibody (<xref rid="B19" ref-type="bibr">19</xref>). For this reason, antibody was coadministered whenever leptin or R128Q were used. The injection volumes were 0.5 ml in the case of intraperitoneal and 0.2 ml in the case of intravenous administration.</p></sec><sec disp-level="3"><title>Statistics.</title><p> The significance of differences in survival time was analyzed by a Log-rank test for curve comparison using a GraphPad Prism computer program (GraphPad Software). In all cases, <italic>P</italic> &#x0003c; 0.05 was considered to be significantly different.</p></sec></sec><sec id="Results"><title>Results</title><sec disp-level="4"><title>Mice Lacking Leptin-signaling Are Highly Sensitive to the Lethal Toxicity of mTNF.</title><p>To assess the role of endogenous leptin induced by TNF, we first tested mutant mouse strains lacking a functional leptin system. Both <italic>ob/ob</italic> and <italic>db/db</italic> mice were challenged with 500 &#x003bc;g/kg mTNF. This dose of TNF, which does not cause lethality in wt mice, resulted in 100 and 80% lethality in <italic>ob/ob</italic> and <italic>db/db</italic> mice, respectively (Fig. <xref ref-type="fig" rid="F1">1</xref>). Therefore, both <italic>ob/ob</italic> and <italic>db/db</italic> mice are far more sensitive to the lethal effect of mTNF (<italic>P</italic> = 0.0001 <italic>ob/ob</italic> versus wt; <italic>P</italic> = 0.0006 <italic>db/db</italic> versus wt). This suggests that a functional leptin system protects against a low dose of mTNF. </p></sec><sec disp-level="4"><title>Exogenous Leptin Protects ob/ob Mice from the Lethal Toxicity of mTNF.</title><p>We tested whether exogenous leptin can protect <italic>ob/ob</italic> mice lacking endogenous leptin. Leptin and 2A5 antibody were administered twice daily for 2 d and at the same time as a challenge with mTNF. In agreement with the previous experiment, <italic>ob/ob</italic> mice exhibited significantly higher sensitivity to TNF as compared with wt mice (Fig. <xref ref-type="fig" rid="F2">2</xref>; <italic>P</italic> = 0.0025 versus wt receiving 2A5 alone). <italic>Ob/ob</italic> mice pretreated with leptin showed resistance comparable to that of wt, and the survival time was significantly longer (<italic>P</italic> = 0.0079 versus <italic>ob/ob</italic> receiving 2A5 alone). There was no significant difference between <italic>ob/ob</italic> mice pretreated with leptin and wt mice. These data confirm our previous evidence that endogenous leptin is protective against the lethal toxicity of TNF and demonstrate that the lack of endogenous leptin can be compensated by administration of exogenous leptin. </p></sec><sec disp-level="4"><title>Leptin Antagonist Sensitizes Normal Mice to the Lethal Toxicity of TNF.</title><p>If sensitization to the toxic effect of TNF in the genetically defective leptin system is fully attributable to leptin (and not to the consequence of secondary effects, such as obesity, elevated levels of insulin, or corticoids), the same sensitization should be obtained in normal lean mice, where the function of leptin is blocked. Therefore, we examined the effect of leptin and leptin antagonist R128Q on the lethal toxicity of mTNF in normal mice. We tested two doses of mTNF that would result in &#x0223c;50 and 0% lethality, respectively, in normal mice. Mice were pretreated with leptin or R128Q antagonist, both in the presence of 100 &#x003bc;g 2A5 antibody per mouse. Treatment with R128Q clearly sensitized mice to TNF toxicity, since 60% died even in response to a low dose of mTNF (Fig. <xref ref-type="fig" rid="F3">3</xref> A; <italic>P</italic> = 0.0008, a significant difference compared with the control group receiving 2A5 alone). Moreover, treatment with R128Q and a higher dose of TNF increased the death toll from 50 to 100%, and the survival time was significantly reduced (Fig. <xref ref-type="fig" rid="F3">3</xref> B; <italic>P</italic> = 0.0063, compared with the control group receiving 2A5 alone). On the other hand, exogenous leptin did not provide any further protection, suggesting that the endogenous leptin level is sufficient for a protective effect. The difference observed between mice pretreated with leptin antagonist and those with antibody alone is due to the functional level of leptin. These experiments allow us to conclude that endogenous leptin protects against TNF-induced lethality. </p></sec></sec><sec id="Discussion"><title>Discussion</title><p>The finding that endogenous leptin plays a protective role against TNF-induced lethality suggests an entirely new property to be attributed to this protein, namely immunomodulatory and antiinflammatory effects. Recently, it was also reported that genetically obese rodents were more susceptible to endotoxin-induced liver injury (<xref rid="B24" ref-type="bibr">24</xref>). This could be explained by increased sensitivity to TNF in the absence of a functional leptin system as shown here. Although increased production of certain proinflammatory cytokines by leptin is reported (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>), these results rather point to a possible impairment of the function of these cytokines by leptin. A recent finding that leptin upregulates suppressors of cytokine signaling 3 (<xref rid="B26" ref-type="bibr">26</xref>) supports such a speculation. The protective role of leptin reminds us of another class of TNF-induced hormones, namely glucocorticoids. Also in this case, mice devoid of a functional glucocorticoid system (by adrenalectomy or administration of a receptor antagonist) are highly sensitized to the toxic effects of TNF (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). The fact that exogenous leptin is able to reverse the increased sensitivity of mice lacking an active leptin system, and that it is ineffective in further decreasing the sensitivity of normal mice, indicates that the leptin levels after TNF induction are high enough to obtain a maximal effect. This is also similar to the situation with glucocorticoids, where adding exogenous hormone could not improve survival in sepsis; on the contrary, blocking the action of this hormone by administering a receptor antagonist, even hours after TNF administration, increased the lethality (<xref rid="B28" ref-type="bibr">28</xref>). TNF activates the hypothalamus pituitary-adrenal axis (HPAA), resulting in a release of glucocorticoids, which in turn attenuate the immune/inflammatory reaction (<xref rid="B29" ref-type="bibr">29</xref>). Both leptin and glucocorticoids induced by TNF itself seem to exert a regulatory negative feedback to prevent the potentially harmful consequences of the proinflammatory cascade. The presence of a bidirectional relationship is suggestive of a coordinated function. Glucocorticoids elevate the leptin level (<xref rid="B30" ref-type="bibr">30</xref>), whereas leptin elicits an effect on HPAA and alters the circulating glucocorticoid levels (<xref rid="B31" ref-type="bibr">31</xref>). Besides, leptin signaling might lead to an enhanced level of another antiinflammatory hormone, &#x003b1;-melanocyte-stimulating hormone (&#x003b1;-MSH; reference <xref rid="B32" ref-type="bibr">32</xref>). It is highly likely that the protective effect of leptin is mediated by &#x003b1;-MSH, which was shown to protect against endotoxin-induced liver injury and mortality (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>). The action of &#x003b1;-MSH resembles that of glucocorticoids in that it inhibits the production of proinflammatory mediators (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B35" ref-type="bibr">35</xref>). Thus a picture emerges that leptin, acting on two parallel antiinflammatory axes, modulates the defence of the body against the TNF-induced inflammatory cascade (Fig. <xref ref-type="fig" rid="F4">4</xref>). Both &#x003b1;-MSH and corticotrophins are derived from the proopiomelanocortin gene and partly share common receptor subtypes. Thus these two arms are also interrelated. One of the receptors for &#x003b1;-MSH, melanocortin-1 receptor, is found on neutrophils and macrophages, and is postulated to mediate the antiinflammatory effects of &#x003b1;-MSH (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B35" ref-type="bibr">35</xref>). However, the antiinflammatory effect of &#x003b1;-MSH involves both central and peripheral signals (<xref rid="B36" ref-type="bibr">36</xref>), suggesting an involvement of yet another receptor subtype that mediates central signaling. Quite intriguingly, it was demonstrated that melanocortin-4 receptor, another MSH receptor, mediated the anorectic effect of leptin (<xref rid="B37" ref-type="bibr">37</xref>). Whether or not this receptor type also plays a role in the potentially antiinflammatory function of leptin should be addressed in the future. The fact that <italic>db/db</italic> mice lacking the functional long form of the leptin receptor (<xref rid="B38" ref-type="bibr">38</xref>) are also sensitized to TNF indicates that signaling through this type of receptor is essential for the protective effect. The leptin receptor belongs to the class-I cytokine receptor family (<xref rid="B16" ref-type="bibr">16</xref>), which suggests an ancestral link between the cytokine system and leptin. Furthermore, leptin itself is structurally related to the cytokines (<xref rid="B39" ref-type="bibr">39</xref>). It is intriguing that there is an overlap between the activities of TNF and leptin (Fig. <xref ref-type="fig" rid="F4">4</xref>). Both TNF and leptin activate the HPAA and melanocortin system (<xref rid="B35" ref-type="bibr">35</xref>), and it appears that leptin provides a redundant way to ensure protection. On the other hand, HPAA exerts a negative feedback on the production of TNF and a positive feedback on leptin production. In this way, the protective pathway induced by TNF can be amplified in the absence of TNF. </p><p>We also found that TNF can still induce weight loss in the absence of a functional leptin system (results not shown). This rules out the mediation of leptin in this effect. Recently, a similar result on endotoxin-induced anorexia was published using <italic>ob/ob</italic> and <italic>db/db</italic> mice (<xref rid="B39" ref-type="bibr">39</xref>). In this case, TNF is presumably a principal mediator, and the study confirms our finding. Therefore, TNF and leptin seem to control the body weight independently. It is not unlikely that both induce either a common mediator or partly common signaling pathways. Recently, a defective melanocortin-4 receptor was shown to cause <italic>agouti</italic>-type obesity (<xref rid="B40" ref-type="bibr">40</xref>). Considering the role of this receptor in leptin-induced anorexia (<xref rid="B37" ref-type="bibr">37</xref>), it is extremely tempting to speculate that it is part of the common pathway. It should be noted that anorectic factors, such as melanocortins and corticotrophin- releasing factor, can be independently activated by TNF and leptin (Fig. <xref ref-type="fig" rid="F4">4</xref>). Here again, factors involved in the immune/neuroendocrine network form a partly common and partly distinct network.</p><p>In conclusion, the finding of a protective role for leptin against TNF toxicity extends the picture of communication between the immune system and the neuroendocrine system. It is attractive to speculate that the leptin system, with its structural relationship to the cytokine system (<xref rid="B41" ref-type="bibr">41</xref>) and functional similarity to glucocorticoids, evolved to form a partly redundant and partly distinct regulatory network to maintain homeostasis both under physiological and pathological conditions. Future studies will clarify the molecular basis underlying the communication among cytokine/glucocorticoid/leptin systems.</p></sec></body><back><ack><p>This work was supported by the Fonds voor Wetenschappelijk Onderzoek&#x02014;Vlaanderen and the Algemene Spaar- en Lijfrentekas. Wim Waelput is a Fellow with the Vlaams Instituut voor de Bevordering van het Wetenschappelijk-technologisch Onderzoek in de Industrie.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vassalli</surname><given-names>P</given-names></name></person-group>
<article-title>The pathophysiology of tumor necrosis factors</article-title>
<source>Annu Rev Immunol</source>
<year>1992</year>
<volume>10</volume>
<fpage>411</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="pmid">1590993</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tracey</surname><given-names>KJ</given-names></name><name><surname>Beutler</surname><given-names>B</given-names></name><name><surname>Lowry</surname><given-names>SF</given-names></name><name><surname>Merryweather</surname><given-names>J</given-names></name><name><surname>Wolpe</surname><given-names>S</given-names></name><name><surname>Milsark</surname><given-names>IW</given-names></name><name><surname>Hariri</surname><given-names>RJ</given-names></name><name><surname>Fahey</surname><given-names>TJ</given-names><suffix>III</suffix></name><name><surname>Zentella</surname><given-names>A</given-names></name><name><surname>Albert</surname><given-names>JD</given-names></name><etal/></person-group>
<article-title>Shock and tissue injury induced by recombinant human cachectin</article-title>
<source>Science</source>
<year>1986</year>
<volume>234</volume>
<fpage>470</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="pmid">3764421</pub-id></element-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="other">Tracey, K.J. 1992. The acute and chronic pathophysiologic effects of TNF: mediation of septic shock and wasting (cachexia). <italic>In</italic> Tumor Necrosis Factors. The Molecules and Their Emerging Role in Medicine. B. Beutler, editor. Raven Press, New York, NY. 255&#x02013;273.</mixed-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fraker</surname><given-names>DL</given-names></name><name><surname>Stovroff</surname><given-names>MC</given-names></name><name><surname>Merino</surname><given-names>MJ</given-names></name><name><surname>Norton</surname><given-names>JA</given-names></name></person-group>
<article-title>Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity</article-title>
<source>J Exp Med</source>
<year>1988</year>
<volume>168</volume>
<fpage>95</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">3294337</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tracey</surname><given-names>KJ</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Manogue</surname><given-names>KR</given-names></name><name><surname>Fong</surname><given-names>Y</given-names></name><name><surname>Hesse</surname><given-names>DG</given-names></name><name><surname>Nguyen</surname><given-names>HT</given-names></name><name><surname>Kuo</surname><given-names>GC</given-names></name><name><surname>Beutler</surname><given-names>B</given-names></name><name><surname>Cotran</surname><given-names>RS</given-names></name><name><surname>Cerami</surname><given-names>A</given-names></name><name><surname>Lowry</surname><given-names>SF</given-names></name></person-group>
<article-title>Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation</article-title>
<source>J Exp Med</source>
<year>1988</year>
<volume>167</volume>
<fpage>1211</fpage>
<lpage>1227</lpage>
<pub-id pub-id-type="pmid">3351436</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Brouckaert</surname><given-names>P</given-names></name><name><surname>Fiers</surname><given-names>W</given-names></name></person-group>
<article-title>Mechanism of tolerance to tumor necrosis factor: receptor-specific pathway and selectivity</article-title>
<source>Am J Physiol</source>
<year>1995</year>
<volume>269</volume>
<fpage>R398</fpage>
<lpage>R405</lpage>
<pub-id pub-id-type="pmid">7653662</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brouckaert</surname><given-names>P</given-names></name><name><surname>Fiers</surname><given-names>W</given-names></name></person-group>
<article-title>Tumor necrosis factor and the systemic inflammatory response syndrome</article-title>
<source>Curr Top Microbiol Immunol</source>
<year>1996</year>
<volume>216</volume>
<fpage>167</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">8791740</pub-id></element-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="other">Munck, A., and P.M. Guyre. 1991. Glucocorticoids and immune function. <italic>In</italic> Psychoimmunology. R. Ader, D. Felten, and N. Cohen, editors. Academic Press, New York, NY. 447&#x02013;479.</mixed-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Castell</surname><given-names>JV</given-names></name><name><surname>G&#x000f3;mez-Lech&#x000f3;n</surname><given-names>MJ</given-names></name><name><surname>David</surname><given-names>M</given-names></name><name><surname>Andus</surname><given-names>T</given-names></name><name><surname>Geiger</surname><given-names>T</given-names></name><name><surname>Trullenque</surname><given-names>R</given-names></name><name><surname>Fabra</surname><given-names>R</given-names></name><name><surname>Heinrich</surname><given-names>PC</given-names></name></person-group>
<article-title>Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes</article-title>
<source>FEBS Lett</source>
<year>1989</year>
<volume>242</volume>
<fpage>237</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="pmid">2464504</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Libert</surname><given-names>C</given-names></name><name><surname>Brouckaert</surname><given-names>P</given-names></name><name><surname>Fiers</surname><given-names>W</given-names></name></person-group>
<article-title>Protection by &#x003b1;<sub>1</sub>-acid glycoprotein against tumor necrosis factor-induced lethality</article-title>
<source>J Exp Med</source>
<year>1994</year>
<volume>180</volume>
<fpage>1571</fpage>
<lpage>1575</lpage>
<pub-id pub-id-type="pmid">7931089</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Libert</surname><given-names>C</given-names></name><name><surname>Van Molle</surname><given-names>W</given-names></name><name><surname>Brouckaert</surname><given-names>P</given-names></name><name><surname>Fiers</surname><given-names>W</given-names></name></person-group>
<article-title>&#x003b1;<sub>1</sub>-antitrypsin inhibits the lethal response to TNF in mice</article-title>
<source>J Immunol</source>
<year>1996</year>
<volume>157</volume>
<fpage>5126</fpage>
<lpage>5129</lpage>
<pub-id pub-id-type="pmid">8943423</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sarraf</surname><given-names>P</given-names></name><name><surname>Frederich</surname><given-names>RC</given-names></name><name><surname>Turner</surname><given-names>EM</given-names></name><name><surname>Ma</surname><given-names>G</given-names></name><name><surname>Jaskowiak</surname><given-names>NT</given-names></name><name><surname>Rivet</surname><given-names>DJ</given-names><suffix>III</suffix></name><name><surname>Flier</surname><given-names>JS</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Fraker</surname><given-names>DL</given-names></name><name><surname>Alexander</surname><given-names>HR</given-names></name></person-group>
<article-title>Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia</article-title>
<source>J Exp Med</source>
<year>1997</year>
<volume>185</volume>
<fpage>171</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="pmid">8996253</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grunfeld</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Fuller</surname><given-names>J</given-names></name><name><surname>Pollack</surname><given-names>A</given-names></name><name><surname>Moser</surname><given-names>A</given-names></name><name><surname>Friedman</surname><given-names>J</given-names></name><name><surname>Feingold</surname><given-names>KR</given-names></name></person-group>
<article-title>Endotoxin and cytokines induce expression of leptin, the <italic>ob</italic>gene product, in hamsters</article-title>
<source>J Clin Invest</source>
<year>1996</year>
<volume>97</volume>
<fpage>2152</fpage>
<lpage>2157</lpage>
<pub-id pub-id-type="pmid">8621806</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Proenca</surname><given-names>R</given-names></name><name><surname>Maffei</surname><given-names>M</given-names></name><name><surname>Barone</surname><given-names>M</given-names></name><name><surname>Leopold</surname><given-names>L</given-names></name><name><surname>Friedman</surname><given-names>JM</given-names></name></person-group>
<article-title>Positional cloning of the mouse <italic>obese</italic>gene and its human homologue</article-title>
<source>Nature</source>
<year>1994</year>
<volume>372</volume>
<fpage>425</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="pmid">7984236</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Graziano</surname><given-names>MP</given-names></name><name><surname>Doebber</surname><given-names>TW</given-names></name><name><surname>Leibowitz</surname><given-names>MD</given-names></name><name><surname>White-Carrington</surname><given-names>S</given-names></name><name><surname>Szalkowski</surname><given-names>DM</given-names></name><name><surname>Hey</surname><given-names>PJ</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Cullinan</surname><given-names>CA</given-names></name><name><surname>Bailey</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Down-regulation of the expression of the <italic>obese</italic> gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and <italic>db/db</italic>mice</article-title>
<source>J Biol Chem</source>
<year>1996</year>
<volume>271</volume>
<fpage>9455</fpage>
<lpage>9459</lpage>
<pub-id pub-id-type="pmid">8621615</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tartaglia</surname><given-names>LA</given-names></name><name><surname>Dembski</surname><given-names>M</given-names></name><name><surname>Weng</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>N</given-names></name><name><surname>Culpepper</surname><given-names>J</given-names></name><name><surname>Devos</surname><given-names>R</given-names></name><name><surname>Richards</surname><given-names>GJ</given-names></name><name><surname>Campfield</surname><given-names>LA</given-names></name><name><surname>Clark</surname><given-names>FT</given-names></name><name><surname>Deeds</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Identification and expression cloning of a leptin receptor, OB-R</article-title>
<source>Cell</source>
<year>1995</year>
<volume>83</volume>
<fpage>1263</fpage>
<lpage>1271</lpage>
<pub-id pub-id-type="pmid">8548812</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frederich</surname><given-names>RC</given-names></name><name><surname>Lollmann</surname><given-names>B</given-names></name><name><surname>Hamann</surname><given-names>A</given-names></name><name><surname>Napolitano-Rosen</surname><given-names>A</given-names></name><name><surname>Kahn</surname><given-names>BB</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Flier</surname><given-names>JS</given-names></name></person-group>
<article-title>Expression of <italic>ob</italic>mRNA and its encoded protein in rodents. Impact of nutrition and obesity</article-title>
<source>J Clin Invest</source>
<year>1995</year>
<volume>96</volume>
<fpage>1658</fpage>
<lpage>1663</lpage>
<pub-id pub-id-type="pmid">7657836</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Campfield</surname><given-names>LA</given-names></name><name><surname>Smith</surname><given-names>FJ</given-names></name><name><surname>Guisez</surname><given-names>Y</given-names></name><name><surname>Devos</surname><given-names>R</given-names></name><name><surname>Burn</surname><given-names>P</given-names></name></person-group>
<article-title>Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks</article-title>
<source>Science</source>
<year>1995</year>
<volume>269</volume>
<fpage>546</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="pmid">7624778</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verploegen</surname><given-names>SABW</given-names></name><name><surname>Plaetinck</surname><given-names>G</given-names></name><name><surname>Devos</surname><given-names>R</given-names></name><name><surname>Van der Heyden</surname><given-names>J</given-names></name><name><surname>Guisez</surname><given-names>Y</given-names></name></person-group>
<article-title>A human leptin mutant induces weight gain in normal mice</article-title>
<source>FEBS Lett</source>
<year>1997</year>
<volume>405</volume>
<fpage>237</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="pmid">9089297</pub-id></element-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="other">Tavernier, J., L. Fransen, A. Marmenout, J. Van der Heyden, R. M&#x000fc;ller, M.R. Ruysschaert, A. Van Vliet, R. Bauden, and W. Fiers. 1987. Isolation and expression of the genes coding for mouse and human tumor necrosis factor (TNF) and biological properties of recombinant TNF. <italic>In</italic> Lymphokines, vol. 13: Molecular Cloning and Analysis of Lymphokines. D.R. Webb and D.V. Goeddel, editors. Academic Press, Orlando, FL. 181&#x02013;198.</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="other">Ruff, M.R., and G.E. Gifford. 1981. Tumor necrosis factor. <italic>In</italic> Lymphokines, vol. 2. E. Pick, editor. Academic Press, New York, NY. 235&#x02013;272.</mixed-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guisez</surname><given-names>Y</given-names></name><name><surname>Fach&#x000e9;</surname><given-names>I</given-names></name><name><surname>Campfield</surname><given-names>LA</given-names></name><name><surname>Smith</surname><given-names>FJ</given-names></name><name><surname>Farid</surname><given-names>A</given-names></name><name><surname>Plaetinck</surname><given-names>G</given-names></name><name><surname>van der Heyden</surname><given-names>J</given-names></name><name><surname>Tavernier</surname><given-names>J</given-names></name><name><surname>Fiers</surname><given-names>W</given-names></name><name><surname>Burn</surname><given-names>P</given-names></name><name><surname>Devos</surname><given-names>R</given-names></name></person-group>
<article-title>Efficient secretion of biologically active recombinant OB protein (leptin) in <italic>Escherichia coli</italic>, purification from the periplasm and characterization</article-title>
<source>Protein Expr Purif</source>
<year>1998</year>
<volume>12</volume>
<fpage>249</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="pmid">9518467</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brouckaert</surname><given-names>P</given-names></name><name><surname>Libert</surname><given-names>C</given-names></name><name><surname>Everaerdt</surname><given-names>B</given-names></name><name><surname>Fiers</surname><given-names>W</given-names></name></person-group>
<article-title>Selective species specificity of tumor necrosis factor for toxicity in the mouse</article-title>
<source>Lymphokine Cytokine Res</source>
<year>1992</year>
<volume>11</volume>
<fpage>193</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="pmid">1420597</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>SQ</given-names></name><name><surname>Lin</surname><given-names>HZ</given-names></name><name><surname>Lane</surname><given-names>MD</given-names></name><name><surname>Clemens</surname><given-names>M</given-names></name><name><surname>Diehl</surname><given-names>AM</given-names></name></person-group>
<article-title>Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>1997</year>
<volume>94</volume>
<fpage>2557</fpage>
<lpage>2562</lpage>
<pub-id pub-id-type="pmid">9122234</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loffreda</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>SQ</given-names></name><name><surname>Lin</surname><given-names>HZ</given-names></name><name><surname>Karp</surname><given-names>CL</given-names></name><name><surname>Brengman</surname><given-names>ML</given-names></name><name><surname>Wang</surname><given-names>DJ</given-names></name><name><surname>Klein</surname><given-names>AS</given-names></name><name><surname>Bulkley</surname><given-names>GB</given-names></name><name><surname>Bao</surname><given-names>C</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><etal/></person-group>
<article-title>Leptin regulates proinflammatory immune responses</article-title>
<source>FASEB (Fed Am Soc Exp Biol) J</source>
<year>1998</year>
<volume>12</volume>
<fpage>57</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">9438411</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bj&#x000f8;rbaek</surname><given-names>C</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name><name><surname>Frantz</surname><given-names>JD</given-names></name><name><surname>Shoelson</surname><given-names>SE</given-names></name><name><surname>Flier</surname><given-names>JS</given-names></name></person-group>
<article-title>Identification of SOCS-3 as a potential mediator of central leptin resistance</article-title>
<source>Mol Cell</source>
<year>1998</year>
<volume>1</volume>
<fpage>619</fpage>
<lpage>625</lpage>
<pub-id pub-id-type="pmid">9660946</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bertini</surname><given-names>R</given-names></name><name><surname>Bianchi</surname><given-names>M</given-names></name><name><surname>Ghezzi</surname><given-names>P</given-names></name></person-group>
<article-title>Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor</article-title>
<source>J Exp Med</source>
<year>1988</year>
<volume>167</volume>
<fpage>1708</fpage>
<lpage>1712</lpage>
<pub-id pub-id-type="pmid">3259257</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brouckaert</surname><given-names>P</given-names></name><name><surname>Everaerdt</surname><given-names>B</given-names></name><name><surname>Fiers</surname><given-names>W</given-names></name></person-group>
<article-title>The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor</article-title>
<source>Eur J Immunol</source>
<year>1992</year>
<volume>22</volume>
<fpage>981</fpage>
<lpage>986</lpage>
<pub-id pub-id-type="pmid">1532365</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharp</surname><given-names>BM</given-names></name><name><surname>Matta</surname><given-names>SG</given-names></name><name><surname>Peterson</surname><given-names>PK</given-names></name><name><surname>Newton</surname><given-names>R</given-names></name><name><surname>Chao</surname><given-names>C</given-names></name><name><surname>McAllen</surname><given-names>K</given-names></name></person-group>
<article-title>Tumor necrosis factor-&#x003b1; is a potent ACTH secretagogue: comparison to interleukin-1&#x003b2;</article-title>
<source>Endocrinology</source>
<year>1989</year>
<volume>124</volume>
<fpage>3131</fpage>
<lpage>3133</lpage>
<pub-id pub-id-type="pmid">2542010</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Slieker</surname><given-names>LJ</given-names></name><name><surname>Sloop</surname><given-names>KW</given-names></name><name><surname>Surface</surname><given-names>PL</given-names></name><name><surname>Kriauciunas</surname><given-names>A</given-names></name><name><surname>LaQuier</surname><given-names>F</given-names></name><name><surname>Manetta</surname><given-names>J</given-names></name><name><surname>Bue-Valleskey</surname><given-names>J</given-names></name><name><surname>Stephens</surname><given-names>TW</given-names></name></person-group>
<article-title>Regulation of expression of <italic>ob</italic>mRNA and protein by glucocorticoids and cAMP</article-title>
<source>J Biol Chem</source>
<year>1996</year>
<volume>271</volume>
<fpage>5301</fpage>
<lpage>5304</lpage>
<pub-id pub-id-type="pmid">8621378</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>MW</given-names></name><name><surname>Seeley</surname><given-names>RJ</given-names></name><name><surname>Campfield</surname><given-names>LA</given-names></name><name><surname>Burn</surname><given-names>P</given-names></name><name><surname>Baskin</surname><given-names>DG</given-names></name></person-group>
<article-title>Identification of targets of leptin action in rat hypothalamus</article-title>
<source>J Clin Invest</source>
<year>1996</year>
<volume>98</volume>
<fpage>1101</fpage>
<lpage>1106</lpage>
<pub-id pub-id-type="pmid">8787671</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thornton</surname><given-names>JE</given-names></name><name><surname>Cheung</surname><given-names>CC</given-names></name><name><surname>Clifton</surname><given-names>DK</given-names></name><name><surname>Steiner</surname><given-names>RA</given-names></name></person-group>
<article-title>Regulation of hypothalamic proopiomelanocortin mRNA by leptin in <italic>ob/ob</italic>mice</article-title>
<source>Endocrinology</source>
<year>1997</year>
<volume>138</volume>
<fpage>5063</fpage>
<lpage>5066</lpage>
<pub-id pub-id-type="pmid">9348241</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lipton</surname><given-names>JM</given-names></name><name><surname>Ceriani</surname><given-names>G</given-names></name><name><surname>Macaluso</surname><given-names>A</given-names></name><name><surname>McCoy</surname><given-names>D</given-names></name><name><surname>Carnes</surname><given-names>K</given-names></name><name><surname>Biltz</surname><given-names>J</given-names></name><name><surname>Catania</surname><given-names>A</given-names></name></person-group>
<article-title>Antiinflammatory effects of the neuropeptide &#x003b1;-MSH in acute, chronic, and systemic inflammation</article-title>
<source>Ann NY Acad Sci</source>
<year>1994</year>
<volume>741</volume>
<fpage>137</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="pmid">7825801</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiao</surname><given-names>H</given-names></name><name><surname>Foster</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Lipton</surname><given-names>J</given-names></name><name><surname>Star</surname><given-names>RA</given-names></name></person-group>
<article-title>&#x003b1;-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation</article-title>
<source>J Clin Invest</source>
<year>1996</year>
<volume>97</volume>
<fpage>2038</fpage>
<lpage>2044</lpage>
<pub-id pub-id-type="pmid">8621792</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Star</surname><given-names>RA</given-names></name><name><surname>Rajora</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Stock</surname><given-names>RC</given-names></name><name><surname>Catania</surname><given-names>A</given-names></name><name><surname>Lipton</surname><given-names>JM</given-names></name></person-group>
<article-title>Evidence of autocrine modulation of macrophage nitric oxide synthase by &#x003b1;-melanocyte-stimulating hormone</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>1995</year>
<volume>92</volume>
<fpage>8016</fpage>
<lpage>8020</lpage>
<pub-id pub-id-type="pmid">7544012</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Macaluso</surname><given-names>A</given-names></name><name><surname>McCoy</surname><given-names>D</given-names></name><name><surname>Ceriani</surname><given-names>G</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Biltz</surname><given-names>J</given-names></name><name><surname>Catania</surname><given-names>A</given-names></name><name><surname>Lipton</surname><given-names>JM</given-names></name></person-group>
<article-title>Antiinflammatory influences of &#x003b1;-MSH molecules: central neurogenic and peripheral actions</article-title>
<source>J Neurosci</source>
<year>1994</year>
<volume>14</volume>
<fpage>2377</fpage>
<lpage>2382</lpage>
<pub-id pub-id-type="pmid">8158274</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seeley</surname><given-names>RJ</given-names></name><name><surname>Yagaloff</surname><given-names>KA</given-names></name><name><surname>Fisher</surname><given-names>SL</given-names></name><name><surname>Burn</surname><given-names>P</given-names></name><name><surname>Thiele</surname><given-names>TE</given-names></name><name><surname>van Dijk</surname><given-names>G</given-names></name><name><surname>Baskin</surname><given-names>DG</given-names></name><name><surname>Schwartz</surname><given-names>MW</given-names></name></person-group>
<article-title>Melanocortin receptors in leptin effects</article-title>
<source>Nature</source>
<year>1997</year>
<volume>390</volume>
<fpage>349</fpage>
<pub-id pub-id-type="pmid">9389472</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Charlat</surname><given-names>O</given-names></name><name><surname>Tartaglia</surname><given-names>LA</given-names></name><name><surname>Woolf</surname><given-names>EA</given-names></name><name><surname>Weng</surname><given-names>X</given-names></name><name><surname>Ellis</surname><given-names>SJ</given-names></name><name><surname>Lakey</surname><given-names>ND</given-names></name><name><surname>Culpepper</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>KJ</given-names></name><name><surname>Breitbart</surname><given-names>RE</given-names></name><etal/></person-group>
<article-title>Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in <italic>db/db</italic>mice</article-title>
<source>Cell</source>
<year>1996</year>
<volume>84</volume>
<fpage>491</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="pmid">8608603</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Faggioni</surname><given-names>R</given-names></name><name><surname>Fuller</surname><given-names>J</given-names></name><name><surname>Moser</surname><given-names>A</given-names></name><name><surname>Feingold</surname><given-names>KR</given-names></name><name><surname>Grunfeld</surname><given-names>C</given-names></name></person-group>
<article-title>LPS-induced anorexia in leptin-deficient (<italic>ob/ob)</italic> and leptin receptor-deficient (<italic>db/db)</italic>mice</article-title>
<source>Am J Physiol</source>
<year>1997</year>
<volume>273</volume>
<fpage>R181</fpage>
<lpage>R186</lpage>
<pub-id pub-id-type="pmid">9249548</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huszar</surname><given-names>D</given-names></name><name><surname>Lynch</surname><given-names>CA</given-names></name><name><surname>Fairchild-Huntress</surname><given-names>V</given-names></name><name><surname>Dunmore</surname><given-names>JH</given-names></name><name><surname>Fang</surname><given-names>Q</given-names></name><name><surname>Berkemeier</surname><given-names>LR</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Kesterson</surname><given-names>RA</given-names></name><name><surname>Boston</surname><given-names>BA</given-names></name><name><surname>Cone</surname><given-names>RD</given-names></name><etal/></person-group>
<article-title>Targeted disruption of the melanocortin-4 receptor results in obesity in mice</article-title>
<source>Cell</source>
<year>1997</year>
<volume>88</volume>
<fpage>131</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">9019399</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Madej</surname><given-names>T</given-names></name><name><surname>Boguski</surname><given-names>MS</given-names></name><name><surname>Bryant</surname><given-names>SH</given-names></name></person-group>
<article-title>Threading analysis suggests that the <italic>obese</italic>gene product may be a helical cytokine</article-title>
<source>FEBS Lett</source>
<year>1995</year>
<volume>373</volume>
<fpage>13</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">7589424</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>Sensitivity of <italic>ob/ob</italic> and <italic>db/db</italic> mice to mTNF-induced lethality. Mice (wt, <italic>ob/ob</italic> and <italic>db/db</italic>) were challenged with 500 &#x003bc;g/kg mTNF intravenously. The percentage of survival was plotted as a function of time (hours after challenge). <italic>n</italic> = 10 (wt) and 5 (<italic>ob/ob</italic> and <italic>db/db</italic>). &#x025cb;, wt; &#x025a1;, <italic>ob/ob</italic>; &#x025b5;, <italic>db/db</italic>. ****<italic>P</italic> = 0.0001 (wt versus <italic>ob/ob</italic>); ***<italic>P</italic> = 0.0006 (wt versus <italic>db/db</italic>). The results shown are representative of three independent experiments.</p></caption><graphic xlink:href="JEM981044.f1"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Effect of leptin pretreatment in <italic>ob/ob</italic> mice receiving a lethal challenge with mTNF. Mice (wt and <italic>ob/ob</italic>) were pretreated as described in Materials and Methods. Doses of 2A5 antibody and leptin were both 100 &#x003bc;g/mouse. Mice were challenged with 500 &#x003bc;g/kg mTNF. The percentage of survival was plotted as a function of time (hours after challenge). For each group, <italic>n</italic> = 5. &#x025cb;, 2A5 in wt mice; &#x025a1;, 2A5 in <italic>ob/ob</italic> mice; &#x025b5;, leptin + 2A5 in <italic>ob/ob</italic> mice. **<italic>P</italic> = 0.0025 (wt versus <italic>ob/ob</italic>); *<italic>P</italic> = 0.0079 (<italic>ob/ob</italic>-2A5 versus <italic>ob/ob</italic>-leptin). The results shown are representative of three independent experiments.</p></caption><graphic xlink:href="JEM981044.f2"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Effect of leptin and leptin antagonist on mTNF-induced lethality. C57BL/6 mice were pretreated with leptin (100 &#x003bc;g/mouse) or R128Q (100 &#x003bc;g/mouse) in combination with 2A5 antibody (100 &#x003bc;g/ mouse) as described in Materials and Methods. Mice were challenged with a low dose (A, 375 &#x003bc;g/kg) or a high dose (B, 750 &#x003bc;g/kg) of mTNF. The percentage of survival was plotted as a function of time (hours after challenge). Each group consisted of 13 mice. The result is a cumulative sum of two independent experiments. (A) &#x025cb;, 2A5; &#x025a1;, leptin + 2A5; &#x025b5;, R128Q + 2A5; ***<italic>P</italic> = 0.0008 (2A5 versus R128Q + 2A5); (B) &#x02022;, 2A5; &#x025aa;, leptin + 2A5; &#x025b4;, R128Q + 2A5. **<italic>P</italic> = 0.0063 (2A5 versus R128Q + 2A5).</p></caption><graphic xlink:href="JEM981044.f3a"/><graphic xlink:href="JEM981044.f3b"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Immune neuroendocrine network involving TNF and leptin. TNF induces a proinflammatory cascade on the one hand and an antiinflammatory protection mechanism on the other hand. &#x02192; , induction; &#x000a2;, inhibition; &#x021d2; , binding to a receptor. GCH, glucocorticoid hormone; OB-R, leptin receptor long form; MC2-R, melanocortin-2 receptor; MCx-R, melanocortin-1 receptor or possibly other subtypes.</p></caption><graphic xlink:href="JEM981044.f4"/></fig></floats-group></article>
